Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas G Forsthuber

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|April 25, 2012
Mast cell TLR2 signaling is crucial for effective killing of Francisella tularensisAnnette R Rodriguez, Jieh-Juen Yu, M Neal Guentzel, et al.
Vaccine|October 8, 2013
A T cell epitope-based vaccine protects against chlamydial infection in HLA-DR4 transgenic miceWeidang Li, Ashlesh K Murthy, Gopala Krishna Lanka, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 2, 2008
Mast cells inhibit intramacrophage Francisella tularensis replication via contact and secreted products including IL-4Jyothi M Ketavarapu, Annette R Rodriguez, Jieh-Juen Yu, et al.
Frontiers in Immunology|April 26, 2021
Inhibition of IL-6 in the LCWE Mouse Model of Kawasaki Disease Inhibits Acute Phase Reactant Serum Amyloid A but Fails to Attenuate VasculitisRebecca A Porritt, Carol Chase Huizar, Edward J Dick, et al.
Neuro-Oncology|February 14, 2025
Immuno-epidemiologic mapping of HLA diversity across glioma patient cohortsZujian Xiong, Kyle M Walsh, Chaim T Sneiderman, et al.
Plos One|April 22, 2016
M-Cells Contribute to the Entry of an Oral Vaccine but Are Not Essential for the Subsequent Induction of Protective Immunity against Francisella tularensisAimee L Cunningham, M Neal Guentzel, Jieh-Juen Yu, et al.
Particle & Particle Systems Characterization : Measurement and Description of Particle Properties and Behavior in Powders and Other Disperse Systems|August 27, 2013
Anti-CRLF2 Antibody-Armored Biodegradable Nanoparticles for Childhood B-ALLRekha Raghunathan, Swetha Mahesula, Kranthi Kancharla, et al.
Electrophoresis|November 20, 2012
Immunoenrichment microwave and magnetic proteomics for quantifying CD47 in the experimental autoimmune encephalomyelitis model of multiple sclerosisSwetha Mahesula, Itay Raphael, Rekha Raghunathan, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 2021
CD11c<sup>+</sup>CD88<sup>+</sup>CD317<sup>+</sup> myeloid cells are critical mediators of persistent CNS autoimmunityNavid Manouchehri, Rehana Z Hussain, Petra D Cravens, et al.
Genes and Immunity|April 3, 2025
Transcript-targeted antigen mapping reveals the potential of POSTN splicing junction epitopes in glioblastoma immunotherapyZujian Xiong, Chaim T Sneiderman, Chloe R Kuminkoski, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Journal of Immunology (Baltimore, Md. : 1950)|April 25, 2012
Mast cell TLR2 signaling is crucial for effective killing of Francisella tularensisAnnette R Rodriguez, Jieh-Juen Yu, M Neal Guentzel, et al.
Vaccine|October 8, 2013
A T cell epitope-based vaccine protects against chlamydial infection in HLA-DR4 transgenic miceWeidang Li, Ashlesh K Murthy, Gopala Krishna Lanka, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 2, 2008
Mast cells inhibit intramacrophage Francisella tularensis replication via contact and secreted products including IL-4Jyothi M Ketavarapu, Annette R Rodriguez, Jieh-Juen Yu, et al.
Frontiers in Immunology|April 26, 2021
Inhibition of IL-6 in the LCWE Mouse Model of Kawasaki Disease Inhibits Acute Phase Reactant Serum Amyloid A but Fails to Attenuate VasculitisRebecca A Porritt, Carol Chase Huizar, Edward J Dick, et al.
Neuro-Oncology|February 14, 2025
Immuno-epidemiologic mapping of HLA diversity across glioma patient cohortsZujian Xiong, Kyle M Walsh, Chaim T Sneiderman, et al.
Plos One|April 22, 2016
M-Cells Contribute to the Entry of an Oral Vaccine but Are Not Essential for the Subsequent Induction of Protective Immunity against Francisella tularensisAimee L Cunningham, M Neal Guentzel, Jieh-Juen Yu, et al.
Particle & Particle Systems Characterization : Measurement and Description of Particle Properties and Behavior in Powders and Other Disperse Systems|August 27, 2013
Anti-CRLF2 Antibody-Armored Biodegradable Nanoparticles for Childhood B-ALLRekha Raghunathan, Swetha Mahesula, Kranthi Kancharla, et al.
Electrophoresis|November 20, 2012
Immunoenrichment microwave and magnetic proteomics for quantifying CD47 in the experimental autoimmune encephalomyelitis model of multiple sclerosisSwetha Mahesula, Itay Raphael, Rekha Raghunathan, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 2021
CD11c<sup>+</sup>CD88<sup>+</sup>CD317<sup>+</sup> myeloid cells are critical mediators of persistent CNS autoimmunityNavid Manouchehri, Rehana Z Hussain, Petra D Cravens, et al.
Genes and Immunity|April 3, 2025
Transcript-targeted antigen mapping reveals the potential of POSTN splicing junction epitopes in glioblastoma immunotherapyZujian Xiong, Chaim T Sneiderman, Chloe R Kuminkoski, et al.
Pageof 8